This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Imprimis Pharmaceuticals Inc (IMMY)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 15.58M 10.04M 146.16K 291.46K
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 15.73M 10.69M 160.96K 351.95K
Property, Plant & Equipment, Gross 26.89K 15.49K 0.00 338.00
Accumulated Depreciation & Depletion 0.00 2.94K 0.00 0.00
Property, Plant & Equipment, Net 26.89K 12.55K 0.00 338.00
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 26.89K 12.55K 0.00 338.00
Liabilities & Shareholder Equity
Total Assets 15.76M 10.71M 160.96K 352.29K
Accounts Payable 261.92K 286.69K 274.70K 73.63K
Short Term Debt 0.00 0.00 300.00K 0.00
Other Current Liabilities 0.00 2.48K 0.00 0.00
Total Current Liabilities 650.63K 709.56K 1.86M 335.04K
Long Term Debt 0.00 0.00 0.00 1.06M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 0.00 0.00 1.06M
Total Liabilities 650.63K 709.56K 1.86M 1.39M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 15.11M 10.00M -1.70M -1.04M
Common Par 8.97K 6.77K 15.90K 15.93K
Additional Paid In Capital 46.85M 34.09M 16.80M 16.41M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -31.75M -24.10M -18.52M -17.47M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 15.11M 10.00M -1.70M 17.26K
Total Equity 15.11M 10.00M -1.70M -1.04M
Total Liabilities & Stock Equity 15.76M 10.71M 160.96K 352.29K
Total Common Shares Outstanding 8.97M 6.77M 397.52K 398.30K
Preferred Shares 0.00 10.00 10.00 10.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 8.66M 4.49M 397.80K 394.63K
Diluted Weighted Shares Outstanding 8.66M 4.49M 397.80K 394.63K
Number of Employees 17 4 2 2
Number of Part-Time Employees 0 1 1 1
IMMY News

IMMY Imprimis Pharmaceuticals Inc

Analysts Ratings for IMMY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
GET IMMY ANALYST REPORT

Brokerage Partners

IMMY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs